NORDITROPIN 5 MG

国: イスラエル

言語: 英語

ソース: Ministry of Health

即購入

公開評価報告書 公開評価報告書 (PAR)
18-08-2016

有効成分:

SOMATROPIN

から入手可能:

NOVO NORDISK LTD., ISRAEL

ATCコード:

H01AC01

医薬品形態:

SOLUTION FOR INJECTION

構図:

SOMATROPIN 3.3 MG / 1 ML

投与経路:

S.C

処方タイプ:

Required

製:

NOVO NORDISK A/S, DENMARK

治療群:

SOMATROPIN

治療領域:

SOMATROPIN

適応症:

Children: Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome. Short stature in children with renal insufficiency. Growth disturbance (current height SDS < - 2.5 and parental adjusted height SDS < - 1) in short children born small for gestational age (SGA) with a birth weight and/or length below - 2 SD who failed to show catch-up growth (HV SDS < during the last year) by 4 years of age or later.Children with short stature associated with Noonan syndrome.Adults: Treatment of adults with Hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of G.H. deficiency. תוספת התוויה: 5/6/2019Indication:Children: Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome.Short stature in children with renal insufficiency.Growth disturbance (current height SDS < -2.5 and parental adjusted height SDS < -1) in short childre

承認日:

2020-05-31

この製品に関連するアラートを検索

ドキュメントの履歴を表示する